Sessa Capital’s Bristol-Myers Squibb BMY Stock Holding History

Sessa Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-144,700	Closed	-$8.59M	–	25
2018 Q2	$8.01M	Sell	144,700 -30,300	-17%	-$1.64M	0.82%	17
2018 Q1	$11.1M	Buy	+175,000	New	+$11.3M	1.18%	16
2017 Q4	–	Sell	-200,000	Closed	-$12.5M	–	28
2017 Q3	$12.7M	Sell	200,000 -150,000	-43%	-$8.76M	1.4%	14
2017 Q2	$19.5M	Hold	350,000	–	–	2.44%	11
2017 Q1	$19M	Buy	350,000 +150,000	+75%	+$8.23M	3.02%	8
2016 Q4	$11.7M	Buy	+200,000	New	+$10.9M	2.2%	12

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Sessa Capital's BMY Position: Q3 2018 in Review

Sessa Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 144,700 shares — an estimated $8.59M sold.

Sessa Capital first reported a position in BMY in Q4 2016 and held it in 6 quarters. The position peaked at $19.5M in Q2 2017. 1,730 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

Sessa Capital reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
Sessa Capital sold 144,700 Bristol-Myers Squibb shares in Q3 2018, an estimated $8.59M.
Sessa Capital first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 6 quarters.
Sessa Capital's Bristol-Myers Squibb position peaked at $19.5M in Q2 2017.
1,730 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Sessa Capital's 13F filing for Q3 2018, filed 14 Nov 2018.